Gilotrif
My Prescription
Payment
Select pharmacy
$12,420.47
Print or send this coupon to your phone
AlbertsonsPowered byAbout Gilotrif
Drug Details
Afatinib, marketed under the brand name Gilotrif, is an oral medication specifically designed to treat certain types of non-small cell lung cancer (NSCLC), particularly when it has progressed or spread. It is typically prescribed to patients whose cancer has specific non-resistant mutations in the EGFR gene or for metastatic squamous NSCLC that has worsened following platinum-based chemotherapy. Afatinib belongs to a class of drugs known as kinase inhibitors, which work by targeting and binding to the epidermal growth factor receptor (EGFR) protein. This protein is often found in higher quantities in cancer cells compared to normal cells, leading to rapid cancer cell growth. By inhibiting EGFR, afatinib helps to slow down or stop the growth of these cancer cells. The medication is taken once daily by mouth and is usually used alone, meaning there is no need for additional anticancer drugs. Patients should be aware that common side effects include diarrhea and skin reactions, which can be severe. As always, it is important to discuss with your healthcare provider before starting any new medication to ensure it is safe and appropriate for your specific condition.
Price history for Gilotrif
30 Tablets, 20MG
Average retail price for Gilotrif
Average SaveHealth price for Gilotrif
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Gilotrif dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 20MG | 30 Tablets | $12,420.47 | $414.02 |
| 30MG | 30 Tablets | $12,420.47 | $414.02 |
| 40MG | 30 Tablets | $12,420.47 | $414.02 |
Gilotrif FAQs
Afatinib is used for the treatment of certain types of non-small cell lung cancer (NSCLC) that have specific mutations in the epidermal growth factor receptor (EGFR) gene. It is typically prescribed when the cancer is advanced or metastatic.
Gilotrif, also known as afatinib, may cause several side effects. Common side effects include diarrhea, rash, acne, mouth sores, and dry skin. Other possible side effects are decreased appetite, nausea, vomiting, and itching. More serious side effects can include liver problems, lung problems, and severe skin reactions. It is important for patients to report any unusual or severe symptoms to their healthcare provider.
The success rate of afatinib can vary depending on the specific type and stage of cancer being treated, as well as individual patient factors. In clinical trials, afatinib has shown efficacy in treating non-small cell lung cancer (NSCLC) with specific genetic mutations, such as EGFR mutations. For patients with these mutations, afatinib has demonstrated improved progression-free survival compared to standard chemotherapy. However, it is important for patients to discuss their specific case with their healthcare provider to understand how afatinib may work for them.
Afatinib is not a cure for cancer, but it is a medication used to treat certain types of cancer, specifically non-small cell lung cancer (NSCLC) with specific genetic mutations. It works by inhibiting the activity of certain proteins that promote cancer cell growth. While it can help manage the disease and improve symptoms, it is not considered a cure. Treatment effectiveness varies among individuals, and it is typically part of a broader treatment plan.
Afatinib may cause several side effects. Common side effects include diarrhea, rash, acne, mouth sores, and dry skin. Other possible side effects are decreased appetite, nausea, vomiting, and fatigue. More serious side effects can include liver problems, lung issues, and severe skin reactions. It is important for patients to report any unusual or severe symptoms to their healthcare provider promptly.